Qinglin Fei

564 total citations
16 papers, 362 citations indexed

About

Qinglin Fei is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Qinglin Fei has authored 16 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Qinglin Fei's work include Pancreatic and Hepatic Oncology Research (9 papers), Immune cells in cancer (4 papers) and Phagocytosis and Immune Regulation (3 papers). Qinglin Fei is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Immune cells in cancer (4 papers) and Phagocytosis and Immune Regulation (3 papers). Qinglin Fei collaborates with scholars based in China, United States and Canada. Qinglin Fei's co-authors include Heguang Huang, Xianchao Lin, Yu Pan, Fengchun Lu, Xunbin Yu, Zelin Hou, Xingxing Yu, Zheyang Zhang, Minggui Pan and Ping Xiong and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Cancer and Cancer Letters.

In The Last Decade

Qinglin Fei

14 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qinglin Fei China	8	210	185	134	52	40	16	362
Changchang Lu China	9	260 1.2×	247 1.3×	131 1.0×	74 1.4×	58 1.4×	20	448
Ahmed Raji Iraq	3	204 1.0×	132 0.7×	97 0.7×	42 0.8×	68 1.7×	8	319
Yusaku Watanabe Japan	9	231 1.1×	139 0.8×	113 0.8×	64 1.2×	45 1.1×	37	360
Eric Fagerberg United States	6	228 1.1×	282 1.5×	137 1.0×	83 1.6×	53 1.3×	9	435
Joseph M. Obeid United States	9	252 1.2×	160 0.9×	132 1.0×	50 1.0×	60 1.5×	13	371
Corey Gallen United States	4	137 0.7×	143 0.8×	87 0.6×	45 0.9×	53 1.3×	6	281
Ioana Plesca Germany	8	252 1.2×	204 1.1×	89 0.7×	63 1.2×	46 1.1×	10	355
Sheryl Kunning United States	7	344 1.6×	305 1.6×	108 0.8×	57 1.1×	71 1.8×	10	503
Matteo Ligorio United States	5	167 0.8×	142 0.8×	97 0.7×	96 1.8×	26 0.7×	7	302
Betül Gök Yavuz United States	6	172 0.8×	137 0.7×	120 0.9×	69 1.3×	34 0.8×	12	325

Countries citing papers authored by Qinglin Fei

Since Specialization

Citations

This map shows the geographic impact of Qinglin Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Fei more than expected).

Fields of papers citing papers by Qinglin Fei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglin Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Fei. The network helps show where Qinglin Fei may publish in the future.

Co-authorship network of co-authors of Qinglin Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglin Fei. A scholar is included among the top collaborators of Qinglin Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglin Fei. Qinglin Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Liu, Huijuan, Guoqiang Guan, Qinglin Fei, et al.. (2025). Yindan Xinnaotong Soft Capsule improves post-ischemic stroke recovery by regulating CREB/BDNF-mediated synaptic plasticity and CREB/VEGFA-mediated angiogenesis. Phytomedicine. 146. 157155–157155.

Ye, Long‐Yun, Mengdi Yang, Wenxia Peng, et al.. (2025). Neurogenic inducers inhibit the proliferation of pancreatic cancer by promoting tumor cell transdifferentiation. Journal of Experimental & Clinical Cancer Research. 44(1). 304–304.

Fei, Qinglin, et al.. (2024). Timing dependent neuronal migration is regulated by Cdk5-mediated phosphorylation of JIP1. Frontiers in Cell and Developmental Biology. 12. 1371568–1371568. 1 indexed citations

Fei, Qinglin, et al.. (2024). Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway. Acta Biochimica et Biophysica Sinica. 56(4). 513–524. 4 indexed citations

Ye, Long‐Yun, et al.. (2023). Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. Cell Death and Disease. 14(11). 778–778. 7 indexed citations

Ye, Long‐Yun, Tianjiao Li, Xing Jin, et al.. (2023). Tissue‐resident CXCR4⁺ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. International Journal of Cancer. 152(11). 2396–2409. 7 indexed citations

Li, Tianjiao, Kaizhou Jin, Hong-Yu Zhou, et al.. (2023). Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma. Cancer Letters. 576. 216411–216411. 15 indexed citations

Jin, Kaizhou, Chen Liu, Cheng He, et al.. (2022). TGF-β1-induced RAP2 regulates invasion in pancreatic cancer. Acta Biochimica et Biophysica Sinica. 54(3). 361–369. 3 indexed citations

Li, Tianjiao, Kaizhou Jin, Hao Li, et al.. (2022). SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. Cancer Letters. 530. 142–155. 35 indexed citations

10.

Yu, Xingxing, Yu Pan, Qinglin Fei, et al.. (2021). Serum soluble PD‐1 plays a role in predicting infection complications in patients with acute pancreatitis. Immunity Inflammation and Disease. 9(1). 310–318. 15 indexed citations

11.

Fei, Qinglin, et al.. (2020). Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma. SHILAP Revista de lepidopterología. 3(3). 147–153. 1 indexed citations

12.

Hou, Zelin, Yu Pan, Qinglin Fei, et al.. (2020). Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 147(2). 517–531. 47 indexed citations

13.

Fei, Qinglin, Yu Pan, Yuanyuan Zhou, et al.. (2020). High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer. Cell Death and Disease. 11(7). 589–589. 45 indexed citations

14.

Pan, Yu, Fengchun Lu, Qinglin Fei, et al.. (2019). Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. Journal of Hematology & Oncology. 12(1). 124–124. 121 indexed citations

15.

Pan, Yu, Qinglin Fei, Ping Xiong, et al.. (2019). Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1. OncoImmunology. 8(5). e1581529–e1581529. 54 indexed citations

16.

Fei, Qinglin, Yuanyuan Zhou, Yixiao Yuan, & Shanquan Sun. (2017). An applied anatomical study of bronchial artery. Surgical and Radiologic Anatomy. 40(1). 55–61. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact